Herpes Simplex Virus Type 2 (HSV2) antibody (FITC)
-
- Target
- Herpes Simplex Virus Type 2 (HSV2)
-
Reactivity
- Herpes Simplex Virus (HSV)
-
Host
-
Sheep
-
Clonality
- Polyclonal
-
Conjugate
- FITC
-
Application
- Immunofluorescence (IF)
- Immunogen
- HSV type 2, strain G (human)
-
-
- Application Notes
-
Suitable for use in ELISA, direct IFA and Western blot.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 4-5 mg/mL (OD280 nm, E0.1% = 1.4)
- Buffer
- 0.01 M PBS, pH 7.2 containing 10 mg/mL BSA as stabilizer and 0.09 % Sodium azide as preservative.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C/-20 °C
- Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Should this product contain a precipitate we recommend microcentrifugation before use.
-
- Target
- Herpes Simplex Virus Type 2 (HSV2)
- Alternative Name
- Herpes Simplex Virus 2 / HSV2
- Target Type
- Virus
- Background
- Herpes simplex type 2 (HSV2) belongs to a family that includes HSV1, Epstein-Barr virus (EBV) and Varicella zoster (chicken pox) virus. HSV1 and HSV2 are extremely difficult to distinguish from each other. These viruses have a DNA genome, an icosahedral protein coat and are encased in a lipid membrane derived from the nuclear membrane of the last host. These viruses are capable of entering a latent phase where the host shows no visible sign of infection and levels of infectious agent become very low. During the latent phase the viral DNA is integrated into the genome of the host cell.Synonyms: HHV2
-